Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 104

    1.

    Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics.

    Terkeltaub R, Bushinsky DA, Becker MA.

    Arthritis Res Ther. 2006;8 Suppl 1:S4. Epub 2006 Apr 12. Review.

    PMID:
    16820043
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    New developments in clinically relevant mechanisms and treatment of hyperuricemia.

    Lee SJ, Terkeltaub RA.

    Curr Rheumatol Rep. 2006 Jun;8(3):224-30. Review.

    PMID:
    16901081
    [PubMed - indexed for MEDLINE]
    3.

    Renal urate handling: clinical relevance of recent advances.

    Anzai N, Enomoto A, Endou H.

    Curr Rheumatol Rep. 2005 Jun;7(3):227-34. Review.

    PMID:
    15919000
    [PubMed - indexed for MEDLINE]
    4.

    [Uricosuric agent].

    Ohno I.

    Nihon Rinsho. 2008 Apr;66(4):743-7. Review. Japanese.

    PMID:
    18409525
    [PubMed - indexed for MEDLINE]
    5.

    [Primary hyperuricemia due to decreased renal uric acid excretion].

    Yamauchi T, Ueda T.

    Nihon Rinsho. 2008 Apr;66(4):679-81. Review. Japanese.

    PMID:
    18409514
    [PubMed - indexed for MEDLINE]
    6.

    Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake: renal organic ion transporter involvement.

    Hu QH, Wang C, Li JM, Zhang DM, Kong LD.

    Am J Physiol Renal Physiol. 2009 Oct;297(4):F1080-91. Epub 2009 Jul 15.

    PMID:
    19605544
    [PubMed - indexed for MEDLINE]
    Free Article
    7.

    Update on emerging urate-lowering therapies.

    Chohan S, Becker MA.

    Curr Opin Rheumatol. 2009 Mar;21(2):143-9. Review. Erratum in: Curr Opin Rheumatol. 2010 Jan;22(1):106.

    PMID:
    19339925
    [PubMed - indexed for MEDLINE]
    8.

    Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate.

    Jutabha P, Anzai N, Kitamura K, Taniguchi A, Kaneko S, Yan K, Yamada H, Shimada H, Kimura T, Katada T, Fukutomi T, Tomita K, Urano W, Yamanaka H, Seki G, Fujita T, Moriyama Y, Yamada A, Uchida S, Wempe MF, Endou H, Sakurai H.

    J Biol Chem. 2010 Nov 5;285(45):35123-32. Epub 2010 Sep 1.

    PMID:
    20810651
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout.

    Ernst ME, Fravel MA.

    Clin Ther. 2009 Nov;31(11):2503-18. Review.

    PMID:
    20109996
    [PubMed - indexed for MEDLINE]
    10.

    Mulberroside a possesses potent uricosuric and nephroprotective effects in hyperuricemic mice.

    Wang CP, Wang Y, Wang X, Zhang X, Ye JF, Hu LS, Kong LD.

    Planta Med. 2011 May;77(8):786-94. Epub 2010 Dec 10.

    PMID:
    21154198
    [PubMed - indexed for MEDLINE]
    11.

    Serum uric acid-lowering therapies: where are we heading in management of hyperuricemia and the potential role of uricase.

    Bomalaski JS, Clark MA.

    Curr Rheumatol Rep. 2004 Jun;6(3):240-7. Review.

    PMID:
    15134605
    [PubMed - indexed for MEDLINE]
    12.

    [New antihyperuricemic medicine: febuxostat, Puricase, etc].

    Ichida K.

    Nihon Rinsho. 2008 Apr;66(4):759-65. Review. Japanese.

    PMID:
    18409528
    [PubMed - indexed for MEDLINE]
    13.

    [Urate transporter and renal hypouricemia].

    Enomoto A, Niwa T, Kanai Y, Endou H.

    Rinsho Byori. 2003 Sep;51(9):892-7. Japanese.

    PMID:
    14560659
    [PubMed - indexed for MEDLINE]
    14.

    [Molecular mechanism in biological transport in the kidney: Urate transporter URAT1].

    Hosoyamada M, Shibasaki T, Ichida K.

    Nihon Rinsho. 2006 Feb;64 Suppl 2:176-9. Review. Japanese. No abstract available.

    PMID:
    16523883
    [PubMed - indexed for MEDLINE]
    15.

    [Historical review of gout and hyperuricemia investigations].

    Nakamura T.

    Nihon Rinsho. 2008 Apr;66(4):624-35. Review. Japanese.

    PMID:
    18409506
    [PubMed - indexed for MEDLINE]
    17.

    [Molecular basis of primary renal hyperuricemia : role of the human urate transporter hURAT1].

    Unger S, Tausche AK, Kopprasch S, Bornstein SR, Aringer M, Grässler J.

    Z Rheumatol. 2007 Nov;66(7):556, 58-61. German.

    PMID:
    17891408
    [PubMed - indexed for MEDLINE]
    18.

    Management of hyperuricemia with rasburicase review.

    de Bont JM, Pieters R.

    Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1431-40. Review.

    PMID:
    15571272
    [PubMed - indexed for MEDLINE]
    19.

    Renal urate transport.

    Mount DB, Kwon CY, Zandi-Nejad K.

    Rheum Dis Clin North Am. 2006 May;32(2):313-31, vi. Review.

    PMID:
    16716882
    [PubMed - indexed for MEDLINE]
    20.

    Febuxostat: a non-purine, selective inhibitor of xanthine oxidase for the management of hyperuricaemia in patients with gout.

    Schumacher HR Jr.

    Expert Opin Investig Drugs. 2005 Jul;14(7):893-903. Review.

    PMID:
    16022578
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk